Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Programming

Health care delivery (1)

Filter by Specific Population

Filter by Topic

Filter by Infection

HIV (remove)
Hepatitis C (1)

Filter by Resource Category

Search results

Current filters: HIV, Treatment, HIV drugs

164 search results

2
3
4
5
6

Alberta clinic explores long-term survival among HIV-positive people: 2018, CATIE
Research summary - Webpage
FDA warns that Prezcobix should not be used by HIV-positive pregnant women: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
CDC recommends use of raltegravir (Isentress) for PEP: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Biktarvy in women with HIV: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Switching from Triumeq to Biktarvy: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Switching to Biktarvy from a protease inhibitor–based regimen: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Biktarvy becomes a treatment option in Canada: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Biktarvy approved in Canada for HIV treatment: 2018, CATIE
Research summary - Webpage
Roche to discontinue supply of saquinavir 200 mg capsule for HIV: 2018, CATIE
Research summary - Webpage
Juluca approved in Canada for HIV treatment: 2018, CATIE
Research summary - Webpage

2
3
4
5
6

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.